Recipe for Enterprise Imaging Strategy

whitePaper | April 26, 2022

The prevalence of communicable and non-communicable diseases are increasing worldwide, placing considerable demand on public health systems and driving a necessity to develop more effective targeted therapies.

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | December 7, 2022

The target market for conducting global clinical trials has changed significantly, moving beyond pharmaceutical early adopters to the mainstream marketplace.

whitePaper | March 31, 2022

This is the fifth annual edition of FH® Healthcare Indicators and FH® Medical Price Index, two measures developed by FAIR Health to provide clarity in a rapidly changing healthcare environment

whitePaper | July 15, 2022

Ensuring critical patient information is available at the point of care is simply non-negotiable. Because without it, patients can’t get the care they need, and the impacts can be life-threatening especially in places like the ER where patients need care immediately, or in the NICU, where every second counts.

whitePaper | November 17, 2021

Nearly every healthcare provider has been hit by ransomware, and the onslaught continues unabated, now affecting patient care with once-unimaginable patient-care consequences. This whitepaper, crafted with healthcare CISOs, details seven critical areas to defend or recover from ransomware attacks. Its pragmatic approach helps ensure business operations and patient care while giving risk teams the tools to manage third parties and other systems involved in business and clinical value chains.